The nice people at the Transfusion Evidence
Alert sent their update today. Again loads to take in, but (in all honesty)
just lately I’ve been struggling to get CPD stuff… there’s loads here with
which I can overload my poor brain…
ARTICLE OF THE MONTH
TOP ARTICLES What influences decisions to donate plasma? A rapid review of the literature.
Berger, M., et al. (2023). Vox Sanguinis. [Record in progress].
Effect of early erythropoietin on retinopathy of prematurity: a stratified meta-analysis.
Fischer, H. S., et al. (2023). Neonatology. [Record in progress].
Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition.
Fox, T., et al. (2023). The Cochrane Database of Systematic Reviews.
The restrictive red blood cell transfusion strategy for critically injured patients (RESTRIC) trial: a cluster-randomized, crossover, non-inferiority multicenter trial of restrictive transfusion in trauma.
Hayakawa, M., et al. (2023). Journal of Intensive Care.
Cost effectiveness of different platelet preparation, storage, selection and dosing methods in platelet transfusion: a systematic review.
Laermans, J., et al. (2023). PharmacoEconomics - Open. [Record in progress].
Definitions of massive transfusion in adults with critical bleeding: a systematic review.
Lin, V. S., et al. (2023). Critical Care.
Comparison of quantitative and calculated postpartum blood loss after vaginal delivery.
Madar, H., et al. (2023). American Journal of Obstetrics & Gynecology MFM. [Record in progress].
Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review.
Mo, A., et al. (2023). Blood Reviews. Maternal anaemia and the risk of postpartum haemorrhage: a cohort analysis of data from the WOMAN-2 trial.
WOMAN-2 trial collaborators (2023). The Lancet. Global Health. |
No comments:
Post a Comment